Stock Earnings

Question 1

Quels sont les états financiers clés de Relay Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Relay Therapeutics Inc a un total d'actifs de $871, un bénéfice net loss de $-337

Question 2

Quels sont les ratios financiers clés pour RLAY ?

Accepted Answer

Le ratio de liquidité de Relay Therapeutics Inc est 9.36, la marge nette est -3,370, les ventes par action sont de $0.06.

Question 3

Comment les revenus de Relay Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Relay Therapeutics Inc largest revenue segment is Dynamo Platform, at a revenue of 10,007,000 in the most earnings release.For geography, United States is the primary market for Relay Therapeutics Inc, at a revenue of 10,007,000.

Question 4

Relay Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Relay Therapeutics Inc a un bénéfice net loss de $-337

Question 5

Relay Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Relay Therapeutics Inc a un passif de 93

Question 6

Combien d'actions en circulation Relay Therapeutics Inc a-t-elle ?

Accepted Answer

Relay Therapeutics Inc a un total d'actions en circulation de 167.75

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	8	10	25	1	3	82
Revenue Growth (YoY)	-87%	-60%	2,400%	-67%	-96%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	69	76	74	65	57	38
Research & Development	291	319	330	246	292	96
Operating Expenses	351	382	398	300	355	138
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-311	-337	-341	-290	-363	-52
Income Tax Expense	--	--	--	--	--	--
Net Income	-311	-337	-341	-290	-363	-230
Net Income Growth	-46%	-1%	18%	-20%	57.99%	206.99%
Shares Outstanding (Diluted)	171.26	142.86	122.57	112.23	95.14	89.91
Shares Change (YoY)	28.99%	17%	9%	18%	6%	3%
EPS (Diluted)	-1.81	-2.36	-2.78	-2.59	-3.82	-2.56
EPS Growth	-59%	-15%	8%	-32%	49%	194%
Free Cash Flow	-262	-251	-304	-238	-77	-104
Free Cash Flow Per Share	-1.52	-1.75	-2.48	-2.12	-0.8	-1.15
Gross Margin	--	--	--	--	--	--
Operating Margin	-4,287.5%	-3,720%	-1,492%	-29,900%	-11,733.33%	-67.07%
Profit Margin	-3,887.5%	-3,370%	-1,364%	-29,000%	-12,100%	-280.48%
Free Cash Flow Margin	-3,275%	-2,510%	-1,216%	-23,800%	-2,566.66%	-126.82%
EBITDA	-339	-367	-368	-295	-349	-52
EBITDA Margin	-4,237.5%	-3,670%	-1,472%	-29,500%	-11,633.33%	-63.41%
D&A For EBITDA	4	5	5	4	3	3
EBIT	-343	-372	-373	-299	-352	-55
EBIT Margin	-4,287.5%	-3,720%	-1,492%	-29,900%	-11,733.33%	-67.07%
Effective Tax Rate	--	--	--	--	--	--

Relay Therapeutics Inc (RLAY) Price

RLAY Stock Price Chart

RLAY Income

Follow-Up Questions